ICMR issues guidelines for Type 1 Diabetes amid surge in Covid-19 cases

According to ICMR study, more and more children are being diagnosed with type 1 diabetes in India

Representative image
Representative image
BS Web Team New Delhi
2 min read Last Updated : Jun 06 2022 | 3:29 PM IST
At a time when the Covid-19 pandemic has disproportionately affected people with diabetes, the Indian Council of Medical Research (ICMR) on Monday released a guidance document for the management of type 1 diabetes.

The first nationwide diabetes prevalence study, funded by the ICMR, reported a narrowing of urban rural difference in the burden of diabetes. As per the study, the disease has becoming apparent in the age group of 25–34 years in both urban and rural areas.

According to ICMR study, more and more children are being diagnosed with type 1 diabetes in India.

The document is a compilation of different chapters on type 1 diabetes dealing right from the epidemiology and diagnosis and differential diagnosis of type 1 diabetes to lifestyle, diet and exercise, insulin, monitoring, acute complications, microvascular complications, and more.

According to ICMR report, lifestyle management  plays an essential role in managing type 1 diabetes mellitus (T1DM). Understanding the effect of diet and physical activity on glycemia is essential for optimal management of T1DM.

The study said all children and adults with T1DM require insulin as soon as they are diagnosed and continuously thereafter throughout life.

In monitoring metabolic control, Diabetes Control and Complications Trial (DCCT) trial provides evidence that achieving good glycemic control in the initial years of T1DM results in reduced incidence of macrovascular and microvascular complications.

According to ICMR report, diabetes was responsible for over four million deaths in 2019 globally and was the leading cause of end-stage kidney disease, adult-onset blindness and cardiovascular diseases. Recent estimates from the International Diabetes Federation suggest that India has the highest number of incident and prevalent cases of type 1 diabetes in the world.



One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :ICMRDiabetes in IndiaCoronavirus TestsHealthcare sector

Next Story